FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034648766> ?p ?o ?g. }

• W3034648766 abstract "Approximately, half of stroke survivors experience fatigue. Fatigue may persist for many months and interferes with participation in everyday activities and has a negative impact on social and family relationships, return to work, and quality of life. Fatigue is among the top 10 priorities for 'Life after Stroke' research for stroke survivors, carers, and clinicians. We previously developed and tested in a small uncontrolled pilot study a manualised, clinical psychologist-delivered, face-to-face intervention, informed by cognitive behavioural therapy (CBT). We then adapted it for delivery by trained therapists via telephone. We now aim to test the feasibility of this approach in a parallel group, randomised controlled feasibility trial (Post Stroke Intervention Trial In Fatigue, POSITIF).POSITIF aims to recruit 75 stroke survivors between 3 months and 2 years post-stroke who would like treatment for their fatigue. Eligible consenting stroke survivors will be randomised to either a 7-session manualised telephone-delivered intervention based on CBT principles plus information about fatigue, or information only. The aims of the intervention are to (i) provide an explanation for post-stroke fatigue, in particular that it is potentially reversible (an educational approach), (ii) encourage participants to overcome the fear of taking physical activity and challenge negative thinking (a cognitive approach) and (iii) promote a balance between daily activities, rest and sleep and then gradually increase levels of physical activity (a behavioural approach). Fatigue, mood, quality of life, return to work and putative mediators will be assessed at baseline (just before randomisation), at the end of treatment and 6 months after randomisation. POSITIF will determine the feasibility of recruitment, adherence to the intervention and the resources required to deliver the intervention in a larger trial.The POSITIF feasibility trial will recruit until 31 January 2020. Data will inform the utility and design of a future adequately powered randomised controlled trial.ClinicalTrials.gov, NCT03551327. Registered on 11 June 2018." @default.
• W3034648766 created "2020-06-19" @default.
• W3034648766 creator A5006770351 @default.
• W3034648766 creator A5007809408 @default.
• W3034648766 creator A5019603770 @default.
• W3034648766 creator A5020521035 @default.
• W3034648766 creator A5020589854 @default.
• W3034648766 creator A5024934572 @default.
• W3034648766 creator A5027229871 @default.
• W3034648766 creator A5049909852 @default.
• W3034648766 creator A5050413666 @default.
• W3034648766 creator A5053459824 @default.
• W3034648766 creator A5068236105 @default.
• W3034648766 creator A5068395945 @default.
• W3034648766 creator A5083774767 @default.
• W3034648766 creator A5083835532 @default.
• W3034648766 creator A5090216616 @default.
• W3034648766 creator A5091307119 @default.
• W3034648766 date "2020-06-15" @default.
• W3034648766 modified "2023-10-04" @default.
• W3034648766 title "Study protocol for POSITIF, a randomised multicentre feasibility trial of a brief cognitive-behavioural intervention plus information versus information alone for the treatment of post-stroke fatigue" @default.
• W3034648766 cites W1579950305 @default.
• W3034648766 cites W1888417836 @default.
• W3034648766 cites W1907220812 @default.
• W3034648766 cites W1926651777 @default.
• W3034648766 cites W1969260656 @default.
• W3034648766 cites W1973017097 @default.
• W3034648766 cites W1985329916 @default.
• W3034648766 cites W1990166011 @default.
• W3034648766 cites W1991724665 @default.
• W3034648766 cites W1998126526 @default.
• W3034648766 cites W2009534082 @default.
• W3034648766 cites W2017646258 @default.
• W3034648766 cites W2018419967 @default.
• W3034648766 cites W2018816554 @default.
• W3034648766 cites W2025144159 @default.
• W3034648766 cites W2043705607 @default.
• W3034648766 cites W2043956062 @default.
• W3034648766 cites W2061523106 @default.
• W3034648766 cites W2065218912 @default.
• W3034648766 cites W2081874228 @default.
• W3034648766 cites W2083208896 @default.
• W3034648766 cites W2087736673 @default.
• W3034648766 cites W2095161487 @default.
• W3034648766 cites W2106783243 @default.
• W3034648766 cites W2110124206 @default.
• W3034648766 cites W2112425786 @default.
• W3034648766 cites W2120019451 @default.
• W3034648766 cites W2128297077 @default.
• W3034648766 cites W2128886654 @default.
• W3034648766 cites W2142993126 @default.
• W3034648766 cites W2166781073 @default.
• W3034648766 cites W2170036462 @default.
• W3034648766 cites W2407521048 @default.
• W3034648766 cites W2408611238 @default.
• W3034648766 cites W2750134942 @default.
• W3034648766 cites W2762603813 @default.
• W3034648766 cites W2809135459 @default.
• W3034648766 cites W4386218079 @default.
• W3034648766 doi "https://doi.org/10.1186/s40814-020-00622-0" @default.
• W3034648766 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7296769" @default.
• W3034648766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32549995" @default.
• W3034648766 hasPublicationYear "2020" @default.
• W3034648766 type Work @default.
• W3034648766 sameAs 3034648766 @default.
• W3034648766 citedByCount "3" @default.
• W3034648766 countsByYear W30346487662022 @default.
• W3034648766 crossrefType "journal-article" @default.
• W3034648766 hasAuthorship W3034648766A5006770351 @default.
• W3034648766 hasAuthorship W3034648766A5007809408 @default.
• W3034648766 hasAuthorship W3034648766A5019603770 @default.
• W3034648766 hasAuthorship W3034648766A5020521035 @default.
• W3034648766 hasAuthorship W3034648766A5020589854 @default.
• W3034648766 hasAuthorship W3034648766A5024934572 @default.
• W3034648766 hasAuthorship W3034648766A5027229871 @default.
• W3034648766 hasAuthorship W3034648766A5049909852 @default.
• W3034648766 hasAuthorship W3034648766A5050413666 @default.
• W3034648766 hasAuthorship W3034648766A5053459824 @default.
• W3034648766 hasAuthorship W3034648766A5068236105 @default.
• W3034648766 hasAuthorship W3034648766A5068395945 @default.
• W3034648766 hasAuthorship W3034648766A5083774767 @default.
• W3034648766 hasAuthorship W3034648766A5083835532 @default.
• W3034648766 hasAuthorship W3034648766A5090216616 @default.
• W3034648766 hasAuthorship W3034648766A5091307119 @default.
• W3034648766 hasBestOaLocation W30346487661 @default.
• W3034648766 hasConcept C118552586 @default.
• W3034648766 hasConcept C127413603 @default.
• W3034648766 hasConcept C141071460 @default.
• W3034648766 hasConcept C142724271 @default.
• W3034648766 hasConcept C15744967 @default.
• W3034648766 hasConcept C168563851 @default.
• W3034648766 hasConcept C169900460 @default.
• W3034648766 hasConcept C1862650 @default.
• W3034648766 hasConcept C2779951463 @default.
• W3034648766 hasConcept C2780645631 @default.
• W3034648766 hasConcept C2780665704 @default.
• W3034648766 hasConcept C2780733359 @default.
• W3034648766 hasConcept C535046627 @default.
• W3034648766 hasConcept C542102704 @default.
• W3034648766 hasConcept C70410870 @default.

• next